Fintel PLC (FNTL)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 169.00 |
|---|---|
| 52-week range | 158.00 – 275.00 |
| Return, 1 month / 3 months | −10.1% / −12.7% |
| Return, 1 year / 3 years | −21.9% / −8.5% |
| Trend | Below its 200-day average |
| RSI (14) | 27 |
| Volatility (1 year) | 36.1% |
| Worst drawdown (1 year) | -41.7% |
| Average daily value traded | 26.52M GBX |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Fintel PLC is a British company that supplies technology, data and compliance services to financial intermediaries. Its software and information products help independent financial advisers, mortgage brokers and other regulated firms manage client relationships, meet regulatory requirements and research products. The company is based in Huddersfield, England, and serves customers across the United Kingdom's financial advice and mortgage markets through subscription-based services.
On this site Fintel PLC appears as a stock on the London Exchange (UK), code FNTL, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Fintel PLC (FNTL) trades on the London Exchange in UK. It last closed at GBX 169.00 on 23 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 2,654 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 21.9% and over the last three months it fell 12.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.1% | ||
| From 52-week high | -37.6% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.7% | ||
| 6-month return | -7.7% | ||
| 12-month return, skipping the last month | -13.1% | ||
| Stability (higher is calmer) | 39 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 36.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.7% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 26.52M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.8% |
|---|---|
| 1 month | −10.1% |
| 3 months | −12.7% |
| 6 months | −7.7% |
| 1 year | −21.9% |
| 3 years | −8.5% |
| 5 years | −15.0% |
Signals
| 50-day / 200-day average | 183.78 / 190.08 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.74 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Sep 2026 | GBP 0.0135 |
| 28 May 2026 | GBP 0.0250 |
| 25 Sep 2025 | GBP 0.0130 |
| 22 May 2025 | GBP 0.0245 |
| 26 Sep 2024 | GBP 0.0120 |
| 23 May 2024 | GBP 0.0235 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.